Comment on

• Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

  Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Kitisin P, Natrujirote P, Kittimunkong S, Chuachoowong R, Gvetadze RJ, McNicholl JM, Paxton LA, Curlin ME, Hendrix CW, Vanichseni S; Bangkok Tenofovir Study Group. Choopanya K, et al. Lancet. 2013 Jun 15;381(9883):2083-90. doi: 10.1016/S0140-6736(13)61127-7. Epub 2013 Jun 13. Lancet. 2013. PMID: 23769234 Clinical Trial.
• HIV antiretroviral prophylaxis for injecting drug users.

  Zhiliang H, Yongfeng Y. Zhiliang H, et al. Lancet. 2013 Sep 7;382(9895):853-4. doi: 10.1016/S0140-6736(13)61855-3. Lancet. 2013. PMID: 24012260 No abstract available.
• HIV antiretroviral prophylaxis for injecting drug users.

  Hudgens MG, Cole SR. Hudgens MG, et al. Lancet. 2013 Sep 7;382(9895):853. doi: 10.1016/S0140-6736(13)61853-X. Lancet. 2013. PMID: 24012261 No abstract available.
• HIV antiretroviral prophylaxis for injecting drug users.

  Miller WC, Hoffman IF, Latkin CA, Strathdee SA, Shoptaw S. Miller WC, et al. Lancet. 2013 Sep 7;382(9895):853. doi: 10.1016/S0140-6736(13)61854-1. Lancet. 2013. PMID: 24012262 No abstract available.
• HIV antiretroviral prophylaxis for injecting drug users.

  Craig AP, Gray R, Jansson J, Wilson DP. Craig AP, et al. Lancet. 2013 Sep 7;382(9895):854-5. doi: 10.1016/S0140-6736(13)61856-5. Lancet. 2013. PMID: 24012263 No abstract available.